No, ibuprofen does not increase your risk of getting coronavirus (COVID-19).
As a leader in the OTC pain category, GSK Consumer Healthcare is committed to consumer safety, and we are constantly re-evaluating the rapidly evolving COVID-19 situation alongside public health authorities. Based on currently available information, The World Health Organization (WHO) does not recommend against the use of ibuprofen, and the Centers for Disease Control and Prevention (CDC) is currently not aware of scientific evidence establishing a link between NSAIDs (e.g., ibuprofen) and worsening of COVID 19.
Consumer safety is our number one priority. Ibuprofen is a well-established medicine that has been used safely for many years as a fever and pain reducer. Our ibuprofen products are effectively used by millions of consumers across 40 markets and have been available as over-the-counter medicines for more than 35 years. All medicines are strictly regulated to ensure they comply with local healthcare authority requirements.